Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 200,000 shares at $42.21 ($8.5M) on 2022-09-15, disclosed to the SEC on 2022-09-15.
Open-market sale of $8.5M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.41 | 47,975 | $2.0M | 24.0% |
| 2 | $42.41 | 47,975 | $2.0M | 24.0% |
| 3 | $42.21 | 52,025 | $2.2M | 26.0% |
| 4 | $42.21 | 52,025 | $2.2M | 26.0% |
| Total | $42.31 avg | 200,000 | $8.5M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |